An FDA advisory committee concluded that BTG's device for treating severe emphysema patients is safe, but the panel raised concerns about the product's efficacy and whether or not the benefits outweigh the risks.
News & Features
Philips said it will acquire Remote Diagnostic Technologies in an effort to expand its Therapeutic Care Business.
Arda Ural of Ernst and Young says there are favorable conditions going on in the medtech industry that could help lead to more acquisitions in the space.
By 2020, new medical device products distributed within Europe must comply with the new European Medical Device Regulation. Is your company ready?
We want to raise the profile of the young people doing groundbreaking work in the medical device and diagnostic industry. Do you know any industry innovators under the age of 30? Tell us who should make the 2018 list! Email nominations to [email protected] with the subject line: Medtech's...
Sirtex Medical said farewell to Varian on Thursday and hitched its wagon to CDH Investments, which had launched a competing bid for Sirtex in May.
OmniVision revealed two new partnerships at MD&M East that will help propel it further into the ever-changing healthcare market.
An expert from Boston Scientific shares insights to help you understand your users and answers questions from industry peers on design validation.
Prescient Medical developed CleanCision, an active cleansing technology used to prevent surgical infections.
If Stryker is, in fact, making a play for Boston Scientific, will Johnson & Johnson enter the fray if a bidding war emerges? Analysts say the chances are pretty good.
Johnson & Johnson accepted Platinum Equity's $2.1 billion offer for LifeScan,the company's blood glucose monitoring unit known for its OneTouch brand of glucose meters and insulin pumps.
Boston Scientific's shares jumped nearly 10% Monday morning after the Wall Street Journal reported that Stryker approached the company with a takeover bid.